{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-059351","form_type":"8-K","ticker":"CHRS","cik":"0001512762","company_name":"Coherus Oncology, Inc.","filed_at":"2025-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.551715+00:00","generated_at":"2026-05-19T08:06:43.501768+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Coherus Oncology annual meeting results: all director nominees elected, say-on-pay and ESPP amendment approved","bullets":["Stockholders elected Jill O'Donnell-Tormey, Michael Ryan, and Ali J. Satvat as Class II directors with 32.8M, 32.7M, and 27.8M votes for, respectively.","Ratified Ernst & Young as independent auditor for FY 2025 with 74.5M votes for, 777K against, 306K abstain.","Advisory say-on-pay resolution approved with 19.2M for, 16.2M against, 3.6M abstain; broker non-votes 36.7M.","Amendment to 2014 Employee Stock Purchase Plan approved with 27.7M for, 7.6M against, 3.6M abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-059351","json":"https://secwatch.observer/filing/0001104659-25-059351.json","markdown":"https://secwatch.observer/filing/0001104659-25-059351.md","text":"https://secwatch.observer/filing/0001104659-25-059351.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512762/000110465925059351/0001104659-25-059351-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512762/000110465925059351/tm2517926d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T08:06:43.501768+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}